CNBC; Gilead Sciences shares surged by more than 15% in after-hours trading Thursday after details leaked of a closely watched clinical trial of the company’s antiviral drug Remdesivir, showing what appears to be promising results in treating Covid-19.   The University of Chicago’s phase 3 drug trial found that most of its patients had “rapid … Continue reading Wuhan Flu: Good News